The Young Adult and Pediatric Bipolar Study
A Phase IV, Multi-Center, Open-Label, Safety and Effectiveness Study of Extended-Release Carbamazepine in the Treatment of Mania in Children and Adolescents Aged 10-17 Years With Acute Manic or Mixed Bipolar I Disorder.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Faktiske)
Tilmelding
Fase
Fase
- Fase 4
Kontakter og lokationer
Studiesteder
-
-
Florida
-
Altamonte Springs, Florida, Forenede Stater, 32701
- 11 Shire Clinical Research Site
-
Fort Lauderdale, Florida, Forenede Stater, 33319
- 17 Segal Institute for Clinical Research
-
Gainesville, Florida, Forenede Stater, 32607
- 19 Sarkis Clinical Trials
-
Jacksonville, Florida, Forenede Stater, 32256
- 23 Shire Clinical Research Site
-
North Miami, Florida, Forenede Stater, 33161
- 21 Scientific Clinical Research
-
-
Georgia
-
Decatur, Georgia, Forenede Stater, 30333
- 14 Northlake Medical Research
-
-
Idaho
-
Eagle, Idaho, Forenede Stater, 83616
- 04 Mountain West Clinical Trials
-
-
Illinois
-
Libertyville, Illinois, Forenede Stater, 60048
- 25 Capstone Clinical Research
-
-
Kansas
-
Overland Park, Kansas, Forenede Stater, 66211
- 15 Psychiatric Associates
-
-
Kentucky
-
Owensboro, Kentucky, Forenede Stater, 42303
- 27 Owensboro Behavioral Care
-
-
Louisiana
-
Shreveport, Louisiana, Forenede Stater, 71101
- 05 Brentwood Research Institute
-
-
Maryland
-
Baltimore, Maryland, Forenede Stater, 21208
- 13 Pharmasite Research, Inc
-
-
New York
-
Rochester, New York, Forenede Stater, 14618
- 02 Finger Lakes Clinical Research
-
-
North Carolina
-
Chapel Hill, North Carolina, Forenede Stater, 27514
- 01 Nccacrf
-
-
Ohio
-
Cincinnati, Ohio, Forenede Stater, 45267
- 06 University of Cincinnati, College of Medicine
-
Cleveland, Ohio, Forenede Stater, 44106
- 09 Discovery and Wellness Center for Children
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Forenede Stater, 73103
- 03 IPS Research
-
-
Pennsylvania
-
Media, Pennsylvania, Forenede Stater, 19063
- 26 Suburban Research Associates
-
-
Texas
-
Bellaire, Texas, Forenede Stater, 77401
- 12 Claghorn-Lesem Research Clinic
-
Dallas, Texas, Forenede Stater, 75235
- 07 Center for Pediatric Psychiatry
-
Houston, Texas, Forenede Stater, 77090
- 24 Red Oak Psychiatry Associates
-
Lake Jackson, Texas, Forenede Stater, 77566
- 10 RID Clinical Research, Inc
-
-
Virginia
-
Midlothian, Virginia, Forenede Stater, 23112
- 08 Dominion Clinical Research
-
Virginia Beach, Virginia, Forenede Stater, 23452
- 22 Brighton Research Group
-
-
Wisconsin
-
Milwaukee, Wisconsin, Forenede Stater, 53201
- 20 Shire Clinical Research Site
-
Milwaukee, Wisconsin, Forenede Stater, 53227
- 16 Rogers Center for Research and Training
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
Key Inclusion Criteria:
- DSM-IV diagnosis of bipolar I disorder, most recent episode manic or mixed.
- A lifetime history of bipolar disorder symptoms for at least 2 months.
- YMRS score greater than or equal to 16.
- CGI-S score greater than or equal to 4.
- Male or female outpatient aged between 10-17 years old inclusive at the time of consent.
- Functioning at an age-appropriate level intellectually, as deemed by the Investigator.
- The subject has no co-morbid illness that could affect efficacy, safety, or tolerability or in any way interfere with the subject's participation in the study.
- Must have a satisfactory medical assessment with no clinically significant and relevant abnormalities.
Exclusion Criteria:
Key Exclusion Criteria:
- Current controlled or uncontrolled, co-morbid psychiatric diagnosis that could interfere with clinical assessments or study conduct.
- A history of lack of therapeutic response or hypersensitivity to the study drug.
- A greater than or equal to 50% reduction in YMRS between Screening and Baseline.
- Acutely at risk for suicidal or violent behavior or a history of suicide attempts requiring medical intervention.
- A history of aplastic anemia, agranulocytosis or bone marrow depression.
- A history of seizure disorder, other than a single childhood febrile seizure.
- A history of severe, unstable asthma.
- Current hospitalization for psychiatric symptoms.
- History of alcohol or other substance abuse or dependence.
- Pregnant or lactating females.
- Body weight less than or equal to 25 kg.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Ikke-randomiseret
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Aktiv komparator: Equetro active
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Safety and tolerability as assessed by the occurrence of treatment emergent adverse events and evaluations of clinical laboratory values, physical examinations, vital signs and ECG data after 6 months of treatment.
Tidsramme: 6 months
|
6 months
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Reduction of bipolar symptoms as assessed by the Young Mania Rating Scale (YMRS), Clinical Global Impressions Scale (CGI) and Children's Depression Rating Scale (CDRS-S) after 6 months of treatment.
Tidsramme: 6 months
|
6 months
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart
Studiestart
Primær færdiggørelse (Faktiske)
Primær færdiggørelse
Studieafslutning (Faktiske)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Lægemidlers fysiologiske virkninger
- Molekylære mekanismer for farmakologisk virkning
- Depressive midler til centralnervesystemet
- Agenter fra det perifere nervesystem
- Analgetika
- Sensoriske systemagenter
- Analgetika, ikke-narkotisk
- Beroligende midler
- Psykotropiske stoffer
- Membrantransportmodulatorer
- Antikonvulsiva
- Natriumkanalblokkere
- Antimaniske midler
- Cytokrom P-450 enzyminducere
- Cytokrom P-450 CYP3A inducere
- Carbamazepin
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- SPD417-311
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .